Atricure Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Public

  • Employees
  • 1,200

Employees

  • Stock Symbol
  • ATRC

Stock Symbol

  • Investments
  • 5

  • Share Price
  • $24.00
  • (As of Wednesday Closing)

Atricure General Information

Description

AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Surgical Devices
Other Industries
Other Devices and Supplies
Stock Exchange
NAS
Corporate Office
  • 7555 Innovation Way
  • Mason, OH 45040
  • United States
+1 (513) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Atricure Stock Performance

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$24.00 $24.73 $18.94 - $59.61 $1.16B 48.4M 863K -$0.80

Atricure Financials Summary

In Thousands,
USD
TTM 31-Mar-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 1,384,835 1,632,891 2,016,210 3,146,738
Revenue 414,602 399,245 330,379 274,329
EBITDA (17,116) (11,901) (31,496) 65,280
Net Income (37,231) (30,438) (46,466) 50,199
Total Assets 591,628 613,932 585,448 615,312
Total Debt 75,363 74,494 74,548 73,891
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Atricure Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Atricure‘s full profile, request access.

Request a free trial

Atricure Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Atricure‘s full profile, request access.

Request a free trial

Atricure Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage
Surgical Devices
Mason, OH
1,200 As of 2023
00000
000000000 00 00000

000000

s nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderi
00000000 0000000
Montreal, Canada
000 As of 0000
00.000 0000-00-00
000000&0

000000

ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate ve
00000000 0000000
Goyang-si, South Korea
000 As of 0000
00000 0000-00-00
000000000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Atricure Competitors (49)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Baylis Medical Company Corporate Backed or Acquired Montreal, Canada 000 000000&0
Lutronic Private Equity-Backed Goyang-si, South Korea 000 000000000000
Elliquence Corporate Backed or Acquired Baldwin, NY 00 000000000 -
Teleflex Corporation Wayne, PA 00000 00.00 000000000000 00.00
Asensus Surgical Formerly VC-backed Durham, NC 000 00000 000000&0 00000
You’re viewing 5 of 49 competitors. Get the full list »

Atricure Patents

Atricure Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240197426-A1 Magnetically coupled ablation components Pending 20-Dec-2022 000000000
US-20240138847-A1 Friction compensating, even pressure clip Pending 26-Oct-2022 00000000000
US-20240122589-A1 Surgical space maker device Pending 14-Oct-2022 00000000000
US-20240115388-A1 Devices and methods for determining clip size for left atrial appendage occlusion Pending 10-Oct-2022 0000000000
US-20240197385-A1 Methods and apparatus for performing ablation of tissue Pending 24-Aug-2022 A61B18/14
To view Atricure’s complete patent history, request access »

Atricure Executive Team (14)

Name Title Board Seat
Michael Carrel President, Chief Executive Officer and Board Member
Angela Wirick Chief Financial Officer
Douglas Seith Chief Operating Officer, Operations
Justin Noznesky Senior Vice President, Marketing and Business Development
Salvatore Privitera JD Chief Technology Officer
You’re viewing 5 of 14 executive team members. Get the full list »

Atricure Board Members (15)

Name Representing Role Since
B. Johnson Self Chairman & Board Member 000 0000
Daniel Florin Self Independent Director 000 0000
Deborah Telman Self Board Member 000 0000
Karen Prange Self Board Member 000 0000
Maggie Yuen Self Board Member 000 0000
You’re viewing 5 of 15 board members. Get the full list »

Atricure Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Atricure Investments & Acquisitions (5)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
SentreHEART 13-Aug-2019 0000000000 00000 Surgical Devices
nContact 13-Oct-2015 0000000000 00000 Surgical Devices 0000000 0
Estech 31-Dec-2013 0000000000 000.00 Medical Supplies
CooperSurgical (Frigitronics cryogenic product) 07-Aug-2007 000000000 00.000 Buildings and Property 00000 000
Enable Medical 10-Aug-2005 Merger/Acquisition 00.000 Surgical Devices
To view Atricure’s complete investments and acquisitions history, request access »

Atricure ESG

Risk Overview

Risk Rating

Updated December, 13, 2023

22.81 | Med Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

00.00

Management

Management is related to actions taken to manage ESG issues

00.00

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

00 of 16,216

Rank

00.00

Percentile

Healthcare

Industry

00 of 643

Rank

00.00

Percentile

Medical Devices

Subindustry

00 of 229

Rank

00.00

Percentile

To view Atricure’s complete esg history, request access »

Atricure FAQs

  • When was Atricure founded?

    Atricure was founded in 2000.

  • Who is the CEO of Atricure?

    Michael Carrel is the CEO of Atricure.

  • Where is Atricure headquartered?

    Atricure is headquartered in Mason, OH.

  • What is the size of Atricure?

    Atricure has 1,200 total employees.

  • What industry is Atricure in?

    Atricure’s primary industry is Surgical Devices.

  • Is Atricure a private or public company?

    Atricure is a Public company.

  • What is Atricure’s stock symbol?

    The ticker symbol for Atricure is ATRC.

  • What is the current stock price of Atricure?

    As of 24-Jul-2024 the stock price of Atricure is $24.00.

  • What is the current market cap of Atricure?

    The current market capitalization of Atricure is $1.16B.

  • What is Atricure’s current revenue?

    The trailing twelve month revenue for Atricure is $415M.

  • Who are Atricure’s competitors?

    Baylis Medical Company, Lutronic, Elliquence, Teleflex, and Asensus Surgical are some of the 49 competitors of Atricure.

  • What is Atricure’s annual earnings per share (EPS)?

    Atricure’s EPS for 12 months was -$0.80.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »